Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of efficacy and complications of OFSAR Wormwood (apsinthion) in CABG patients
IRCT2013120715696N1Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of wormwood in coronary arteriosclerosis, sponsored by Hamadan University of Medical Sciences. Started Jan 2014; status: completed.
02
Drugs
wormwood
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT2013120715696N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013120715696N1.